Perriman Damien Alan
SEC insider (Form 3/4/5 filer). CIK 0002096714. Chief Commercial Officer at EXOZYMES INC. (EXOZ). 5 reported Form 4/5 transactions since Sep 2024; latest on Oct 12, 2026. Located in MONROVIA, CA.
Companies Perriman Damien Alan has filed insider reports for
- EXOZYMES INC. (EXOZ): Officer, Chief Commercial Officer
Perriman Damien Alan
CIK: 0002096714
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (20.0%)
Position reduction
Option Exercises (M)2 (40.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EXOZ
EXOZYMES INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Oct 12, 2026EXOZ
EXOZYMES INC.
SaleDirect3.7K shares at avg. $5.21$19K - Oct 9, 2026EXOZ
EXOZYMES INC.
ExerciseDirect3.9K shares- - Aug 19, 2026EXOZ
EXOZYMES INC.
ExerciseDirect19.6K shares- - Apr 1, 2026EXOZ
EXOZYMES INC.
AwardDirect62.8K shares- - Apr 1, 2026EXOZ
EXOZYMES INC.
AwardDirect8.9K shares at avg. $8.44$75K
1-5 of 5 transactions